$1.46 -0.02 (-1.35%)
11/27/2009 1:00 PM

AVI BioPharma, Inc. (AVII)

CAPS Rating: 4 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Featured Broker Partners